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Abstract.
 
Objectives
 
: Embryonic stem cells are a potential source for insulin-producing
cells, but existing differentiation protocols are of limited efficiency. Here, the aim has
been to develop a new one, which drives development of embryonic stem cells towards
insulin-producing cells rather than to neuronal cell types, and to combine this with a
strategy for their separation from insulin-negative cells. 
 
Materials and methods
 
: The
cytokeratin-19 (CK19) promoter was used to control the expression of enhanced yellow
fluorescence protein in mouse embryonic stem cells during their differentiation towards
insulin-producing cells, using a new optimized four-stage protocol. Two cell populations,
CK19
 
+
 
 and CK19
 
–
 
 cells, were successfully fluorescence sorted and analysed. 
 
Results
 
:
The new method reduced neuronal progeny and suppressed differentiation into glucagon-
and somatostatin-producing cells. Concomitantly, 
 
β
 
-cell like characteristics of insulin-
producing cells were strengthened, as documented by high gene expression of the
Glut2 glucose transporter and the transcription factor Pdx1. This novel protocol was
combined with a cell-sorting technique. Through the combined procedure, a fraction of
glucose-responsive insulin-secreting CK19
 
+
 
 cells was obtained with 40-fold higher insulin
gene expression and 50-fold higher insulin content than CK19
 
–
 
 cells. CK19
 
+
 
 cells were
immunoreactive for C-peptide and had ultrastructural characteristics of an insulin-
secretory cell. 
 
Conclusion
 
: Differentiated CK19
 
+
 
 cells reflect an endocrine precursor cell
type of ductal origin, potentially suitable for insulin replacement therapy in diabetes.
INTRODUCTION
 
The differentiation protocol by Lumelsky 
 
et al
 
. (2001), originally established to differentiate
mouse embryonic stem cells (ESCs) into neuronal cells (Lee 
 
et al
 
. 2000), has also been a
reference tool for differentiation of mouse ESCs towards insulin-producing cells; however, its
efficiency is low (Paek 
 
et al
 
. 2005). Various other alternative mouse ESC differentiation methods
have been developed, but the results of these activities have also been disappointing, due to
limited efficiency and reproducibility (Soria 
 
et al
 
. 2000; Hori 
 
et al
 
. 2002). The yield of insulin-
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producing cells is usually so low that the amount of insulin they produce cannot be reliably
quantified, in particular when tissue culture media contain insulin (Rajagopal 
 
et al
 
. 2003;
Hansson 
 
et al
 
. 2004). Thus, it has been doubted whether cells obtained during the course of such
experiments may be suited for reproducible generation of insulin-producing cells (Sipione 
 
et al
 
.
2004). With a few exceptions (Soria 
 
et al
 
. 2000; Leon-Quinto 
 
et al
 
. 2004; Roche 
 
et al
 
. 2005;
Vaca 
 
et al
 
. 2006), work on ESC differentiation towards insulin-producing cells has been focused
on variation of cell culture conditions (Lumelsky 
 
et al
 
. 2001; Hori 
 
et al
 
. 2002; Moritoh 
 
et al
 
.
2003; Bai 
 
et al
 
. 2005; Shi 
 
et al
 
. 2005) or overexpression of transcription factors that are known
to be important for pancreatic organogenesis (Blyszczuk 
 
et al
 
. 2003; Miyazaki 
 
et al
 
. 2004;
Shiroi 
 
et al
 
. 2005). However, none of these have been suited to separate insulin-producing cells
from other cell types, which also develop during differentiation.
In Lumelsky
 
 et al
 
.’s original method, the idea was put forward that ESCs may differentiate
 
in vitro
 
 into nestin-positive endocrine precursor cells that would differentiate further towards
insulin-producing cells. This approach was based on the assumption that 
 
β
 
-cell neogenesis in the
pancreas results from differentiation of nestin-positive cells, as such a population is resident
in adult pancreas (Hunziker & Stein 2000; Zulewski 
 
et al
 
. 2001). However, participation of
nestin-positive cells in 
 
β
 
-cell regeneration is doubtful (Selander & Edlund 2002; Treutelaar 
 
et al
 
.
2003). In addition to nestin-positive cells, another cell population, namely cytokeratin-19-
positive (CK19
 
+
 
) ductal cells, have been considered to be a pool for newly derived 
 
β
 
-cells during
pancreatic organogenesis (Rutter 1980; Slack 1995; Bouwens 
 
et al
 
. 1997; Bonner-Weir 
 
et al
 
.
2000; Bouwens & Rooman 2005). In the mouse, pancreatic primordia develop from the
primitive gut tube stage after gastrulation, from a Pdx1-expressing cell population (Edlund
2002). The pancreas at this stage exists as separate dorsal and ventral buds, which grow in size
and later fuse to form the definitive pancreatic tissue. In contrast, several studies have doubted
the hypothesis of neuroectodermal origin of the 
 
β
 
-cells, and that pancreatic endocrine cells may
develop from duct-like cells that migrate into the surrounding mesenchyme and differentiate into
the four major hormone-expressing cell types (Rutter 1980). Most importantly, these transitional
cells would express CK19 and co-express insulin (Bouwens & De Blay 1996; Bouwens 
 
et al
 
.
1997; Bouwens & Pipeleers 1998). Such ductal cells have shown capacity to proliferate and
differentiate 
 
in vitro
 
 into islet cells (Bonner-Weir 
 
et al
 
. 2000; Gao 
 
et al
 
. 2003, 2005). Moreover,
re-expression of 
 
β
 
-cell specific transcription factor Pdx1 has been observed in ductal cells when
placed in cell culture, indicating an early endocrine precursor cell type (Gmyr 
 
et al
 
. 2000). In
addition to these findings, participation of CK19 during differentiation towards insulin-producing
cells has been observed in mouse (Blyszczuk 
 
et al
 
. 2004) and recently in human (Jiang 
 
et al
 
. 2007)
embryonic stem cell lines. Not surprisingly, appearance of CK19
 
+
 
 cells in ESCs undergoing
 
in vitro
 
 differentiation towards insulin-producing cells reflects a mechanism analogous to that
described for differentiation of ductal tissue into insulin-producing cells during foetal development
of the pancreas (Gao 
 
et al
 
. 2003; Noguchi 
 
et al
 
. 2003; Bonner-Weir 
 
et al
 
. 2004). However, efficient
generation of insulin-producing cells from ESCs requires not only a reliable differentiation
method, but in addition a sensitive cell separation strategy. To overcome the drawbacks of the
reference protocol, we have established a new straightforward and optimized four-stage strategy
that minimizes neuronal differentiation potential and suppresses differentiation into glucagon-
and somatostatin-producing cells. We have combined this with a cell-sorting technique based on
fluorescence-activated cell sorter (FACS) analysis. Specifically, the CK19 promoter was used to
control expression of enhanced yellow fluorescence protein (eYFP) in mouse ESCs during their
differentiation towards insulin-producing cells. Two distinct cell populations, CK19
 
+
 
 and CK19
 
–
 
cells, were successfully separated and analysed. This approach yielded an insulin-producing cell
type from CK19
 
+
 
 endocrine precursors.
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MATERIALS AND METHODS
 
Materials
 
Dulbecco’s modified Eagle’s medium (DMEM) and DMEM/F-12 tissue culture media,
glutamine, non-essential amino acids and basic fibroblast growth factor (bFGF) were obtained
from Invitrogen (Karlsruhe, Germany). Foetal calf serum (FCS) embryonic stem cell grade and
gentamicin were purchased from PAA (Vienna, Austria) and leukaemia inhibitory factor (LIF)
from Chemicon (Temecula, CA, USA). Insulin, transferrin, sodium selenite, putrescine and pro-
gesterone were from Sigma (St. Louis, MO, USA). All primer pairs, including random hexamer
primers, were synthesized by MWG (Munich, Germany). The RevertAid™ H Minus M-MuLV
Reverse Transcriptase was from Fermentas (St. Leon-Rot, Germany). Biotherm™ Taq polymerase
as well as the deoxynucleoside triphosphates were from Genecraft (Münster, Germany). SYBR
Green I was from Biozym (Hess. Oldendorf, Germany) and plastic ware for real-time polymerase
chain reaction (PCR) reactions were from Abgene (Hamburg, Germany). C-peptide antibody
was from Linco Research (St. Charles, MS, USA) and insulin antibody from Abcam (Cambridge,
UK). Secondary antibodies were provided by Dianova (Hamburg, Germany). Unless otherwise
mentioned, chemicals of analytical grade were obtained from Sigma or Merck (Darmstadt,
Germany).
 
Plasmid construction and transfection
 
The pGL3-CK19 backbone vector was kindly provided by Dr. Shuichi Kaneko (Kanazawa
University, Kanazawa, Japan). The luciferase sequence downstream of the 2.9 kb CK19 promoter
fragment was removed by DNA digestion with 
 
Hin
 
dIII and 
 
Xba
 
I. Subsequently, cDNA of eYFP
was purified by DNA digestion from the pEYFP-N1 vector (Clontech, Mountain View, CA,
USA) as described above and was subcloned into the linearized pGL3-CK19 vector. In the
obtained gene cassette, the human CK19 promoter drives the expression of eYFP followed by
a poly(A) signal. ES-D3 cells were co-transfected with pCK19-eYFP and pCDNA3 plasmid
featuring a neomycin gene for cell selection. Cell transfections were performed with Effectene
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions. Resistant clones were
selected, using 300 
 
μ
 
g/mL G418, and successful integration of the construct was verified by RT-
PCR from genomic DNA. Five different YFP clones were generated and on the basis of analysis
of fluorescence intensity, the best clone was selected for detailed analyses in the present study.
Resulting transgenic embryonic stem cells were designated ES-D3 CK19-eYFP.
 
Cell lines and culture conditions
 
The mouse embryonic stem cell line ES-D3 (Doetschman 
 
et al
 
. 1985) was purchased from the
American Tissue Culture Collection (Manassas, VA, USA). These cells were differentiated
towards insulin production using a new four-stage differentiation protocol and results were
compared to those of a previously published method (Lumelsky 
 
et al
 
. 2001). In order to maintain
the cells in an embryonic state, they were cultured on a feeder layer of mouse embryonic
fibroblasts in DMEM containing 25 m
 
m
 
 glucose and supplemented with 15% (v/v) FCS,
2 m
 
m
 
 
 
l
 
-glutamine, 100 
 
μ
 
m
 
 non-essential amino acids, 0.1 m
 
m
 
 
 
β
 
-mercaptoethanol, 50 
 
μ
 
g/mL
gentamicin and 1000 U/mL LIF in a humidified atmosphere at 37 
 
°
 
C and 5% CO
 
2
 
. Medium was
changed every day. Subsequently, the cells were transferred for two passages on to gelatin-coated
tissue culture dishes to remove them from the feeder layer.
For differentiation with the new protocol, the cells were trypsinized and counted using a
haemocytometer. One million cells were transferred to a bacterial culture dish in medium, as
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described above, but devoid of LIF. Cells were then grown for up to 5 days in suspension. During
this time, embryoid bodies formed that were allowed to settle on to gelatin-coated dishes in
serum-free DMEM/F-12 medium supplemented with 25 
 
μ
 
g/mL insulin, 50 
 
μ
 
g/mL transferrin,
30 n
 
m sodium selenite, 20 nm progesterone, 100 μm putrescine, 2 mm l-glutamine, 100 μm non-
essential amino acids and 10 ng/mL bFGF, for 14 days. Thereafter, the cells were cultured for
7 days in DMEM/F-12 medium supplemented with 25 μg/mL insulin, 50 μg/mL transferrin,
30 nm sodium selenite, 20 nm progesterone, 100 μm putrescine, 5% FCS, 2 mm l-glutamine,
1× non-essential amino acids and 10 mm nicotinamide.
FACS analysis and cell sorting
ES-D3 CK19-eYFP cells at different time points along the new differentiation protocol were
trypsinized, centrifuged and re-suspended in Krebs–Ringer buffer supplemented with 1 mm
EDTA and 20% FCS. They were then filtered through a 40-μm gauze and sorted on a MoFlo
cell sorter into CK19+ and CK19– cell populations (DakoCytomation, Fort Collins, CO, USA).
Molecular biology
Total RNA was isolated from ESCs using the Chomczynski system (Chomczynski & Sacchi
1987). RNA was quantified photometrically and analysed on a denaturing agarose gel. For
cDNA synthesis, random hexamers were used to prime the reaction of RevertAid™ H Minus
M-MuLV reverse transcriptase. QuantiTect SYBR Green™ technology (Qiagen, Hilden, Germany),
which uses a fluorescent dye that binds only double-stranded DNA, was employed. Reactions
were performed using DNA Engine Opticon™ Sequence Detection System (Biozym Diagnostik,
Hess. Oldendorf, Germany). Samples were first denatured at 94 °C for 3 min followed by 40 PCR
cycles. Each cycle comprised a melting step at 94 °C for 30 s, an annealing step at 62 °C for 30 s,
and an extension step at 72 °C for 30 s. Each PCR amplification was performed in triplicate
using primers for insulin (detecting both Ins1 and Ins2), glucagon, somatostatin, nestin, Glut2,
Pdx1, Nkx6.1, Kir6.2, Sur1, glucokinase, Oct4, neural cell adhesion molecule (NCAM), β-actin,
CK19, carbonic anhydrase 2, amylase 2 and albumin (Table 1). Optimal parameters for PCRs
were empirically defined. Purity of amplified PCR products was verified by melting curves. Data
are expressed as relative gene expressions after normalization to the β-actin housekeeping gene
using Qgene96 and LineRegPCR software (Muller et al. 2002; Ramakers et al. 2003).
Ultrastructural characterization
For electron microscopy, cell pellets of ESCs and MIN6 cells (Miyazaki et al. 1990) were fixed
in 2% paraformaldehyde plus 2% glutaraldehyde in 0.1 m cacodylate buffer, pH 7.3 and were
post-fixed in 1% OsO4 then finally embedded in Epon resin. Ultrathin sections were contrast-
stained with saturated solutions of lead citrate and uranyl acetate and were viewed by electron
microscopy (Gurgul et al. 2004).
Immunostaining and microscopy
Immunocytochemical co-staining for C-peptide and insulin was performed according to standard
procedures. 0.5–1 × 104 FACS-sorted ESCs and MIN6 cells as positive controls were seeded
overnight on glass slides and then fixed in 4% paraformaldehyde for 30 min. Thereafter, cells
were blocked for 20 min in phosphate-buffered saline (PBS) plus 0.2% Triton X-100, 1% bovine
serum albumin (BSA) and 5% donkey serum. Incubation with anti-C-peptide antibody was
performed at room temperature for 60 min, diluted 1 : 100 in PBS with 0.1% BSA followed by
incubation with Cy5-conjugated secondary antibody diluted 1 : 500 in PBS + 0.1% BSA for
30 min. Incubation with anti-insulin antibody was also performed at room temperature for
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120 min diluted 1 : 100 in PBS with 0.1% BSA, followed by incubation with Texas Red or
FITC-conjugated secondary antibody diluted 1 : 500 in PBS + 0.1% BSA for 30 min. Subsequently,
the cells were washed and nuclei were counterstained with 300 nm 4′,6-diamidino-2-phenylin-
dole (DAPI) for 5 min at room temperature. Finally, the cells were washed and mounted with
Mowiol/DABCO antiphotobleaching mounting media. Stained cells were examined on an
Olympus IX81 inverted microscope (Olympus, Hamburg, Germany) and microscopy images
were post-processed with AutoDeblur and AutoVisualize (Autoquant Imaging, New York, USA).
Insulin secretion and insulin content
Cells were seeded at a density of 1 × 105/well in 48-well culture dishes and were grown for 24 h
in DMEM/F-12 medium without insulin and supplemented with 5.5 mm glucose; they were then
Table 1. Primers used for qRT-PCR. All amplicons were designed exon-spanning and were in a size ranging from 100
to 300 bp
Gene Primer sequence
Insulin Fw 5′-CCCACCCAGGCTTTTGTCAAACAGC-3′
Rv 5′-TCCAGCTGGTAGAGGGAGCAGATG-3′
Glucagon Fw 5′-CAGGGCACATTCACCAGCGACTAC-3′
Rv 5′-TCAGAGAAGGAGCCATCAGCGTG-3′
Somatostatin Fw 5′-ATGCTGTCCTGCCGTCTCCA-3′
Rv 5′-TGCAGCTCCAGCCTCATCTCG –3′
Nestin Fw 5′-GAGAGTCGCTTAGAGGTGCA-3′
Rv 5′-CCACTTCCAGACTAAGGGAC-3′
Glut2 Fw 5′-GAAGACAAGATCACCGGAACCTTGG-3′
Rv 5′-GGTCATCCAGTGGAACACCCAAAA-3′
Pdx1 Fw 5′-ACCGCGTCCAGCTCCCTTTC-3′
Rv 5′-CAACATCACTGCCAGCTCCACC-3′
Nkx6.1 Fw 5′-AGAACCGCAGGACCAAGTGGAGAA-3′
Rv 5′-TCGTCATCCTCCTCATTCTCCGAAG-3′
Kir6.2 Fw 5′-TGCTGTCCCGAAAGGGCATTATC-3′
Rv 5′-TGCAGTTGCCTTTCTTGGACACG-3′
Sur1 Fw 5′-ACCAAGGTGTCCTCAACAACGGCT-3′
Rv 5′-TGGAGCCAGGTGCTATGGTGAATG-3′
Glucokinase Fw 5′-GAGGTCGGCATGATTGTGGGCA-3′
Rv 5′-GCGCCCCACTCTGTGTTGACACAC-3′
Oct 4 Fw 5′-AGGCCCGGAAGAGAAAGCGAACTA-3′
Rv 5′-TGGGGGCAGAGGAAAGGATACAGC-3′
NCAM Fw 5′-CGACGAGGCCGAATACGTCTG-3′
Rv 5′-GCTCCTCTAGTTCCATGGCCGTC-3′
β-Actin Fw 5′-AGAGGGAAATCGTGCGTGAC-3′
Rv 5′-CAATAGTGATGACCTGGCCGT-3′
Cytokeratin 19 Fw 5′-GGTGCCACCATTGACAACTC-3′
Rv 5′-CTGCATCTCCAGGTCAGTCC-3′
Carbonic anhydrase 2 Fw 5′-CCACCACTGGGGATACAGCAAGC-3′
Rv 5′-GTCCTCCTTTCAGCACTGCATTGTC-3′
Amylase 2 Fw 5′-CTGTGAACACAGATGGCGTCAAATC-3′
Rv 5′-GCAGGAAGACCAGTCTGTAAAGTGGC-3′
Albumin Fw 5′-CCTCCTCTTCGTCTCCGGCTCTG-3′
Rv 5′-GGGATTTGTCACAGTTGGCGGC-3′
Fw, forward (sense) primer; Rv, reverse (antisense) primer; NCAM, neural cell adhesion molecule.
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washed with Krebs–Ringer buffer. Insulin secretion during a 120-min incubation period was
measured in Krebs–Ringer buffer containing 0 mm and 30 mm glucose. After incubation,
medium was removed and gently centrifuged to remove detached cells. Insulin was measured in
the supernatant. For measurement of insulin content, cells were sonicated in Krebs–Ringer
buffer. Insulin was determined by radioimmunoassay using rat insulin as standard.
Statistical analyses
Data are expressed as mean values ± SEM. Unless stated otherwise statistical analyses were
performed using anova followed by Bonferroni’s test for multiple comparisons or t-test for
paired correlations, using the Prism analysis program (GraphPad, San Diego, CA, USA).
RESULTS
Comparison of the gene expression profile after differentiation of ESCs according to the 
reference differentiation protocol or to the optimized four-stage differentiation protocol
Quantitative analysis of gene expression in mouse ESCs, which had been differentiated according
to the reference protocol by Lumelsky et al. (2001), showed that all three major pancreatic
endocrine hormones, insulin, glucagon and somatostatin were readily expressed. In contrast,
ESCs differentiated according to the new optimized four-stage differentiation protocol expressed
insulin almost exclusively, while glucagon expression was not detectable and somatostatin
expression was low when compared to the reference protocol (Table 2, Fig. 1).
The structural marker genes glucokinase, Kir6.2 and Sur1, which play a crucial role in β-
cell stimulus-secretion coupling, were well expressed in cells from both protocols. In addition,
expression of CK19 and carbonic anhydrase 2 (CA2), both markers for pancreatic duct cells,
were increased significantly by 6-fold and 9-fold, respectively (Table 2). Interestingly, Sur1
Table 2. Comparison of the relative gene expression profile of unsorted mouse embryonic stem cells, comprising
pancreatic hormones, transcription factors and structural markers, after differentiation into insulin-producing cells,
according to the reference protocol by Lumelsky et al. (2001), or to the optimized four-stage differentiation protocol
Reference protocol (%) Optimized four-stage protocol (%)
Insulin 100 ± 24 (6) 136 ± 27 (13)
Glucagon 100 ± 32 (5) n.d.
Somatostatin 100 ± 38 (5) 11 ± 4 (11)
Pdx1 100 ± 52 (4) 1184 ± 438 (13)
Glut2 100 ± 24 (4) 338 ± 98 (10)
Glucokinase 100 ± 24 (6) 122 ± 29 (10)
Kir6.2 100 ± 7 (4) 96 ± 24 (12)
Sur1 100 ± 23 (6) 182 ± 47 (10)
Nestin 100 ± 32 (4) 49 ± 12 (10)
NCAM 100 ± 20 (5) 16 ± 4 (6)
Carbonic anhydrase 2 100 ± 29 (4) 561 ± 103 (11)
Cytokeratin-19 100 ± 22 (5) 895 ± 81 (10)
Data shown are gene expression values determined by qPCR on day 26 of differentiation. Depicted are the changes in 
relative expression in percentage, normalized to the reference protocol by Lumelsky et al. (2001). Values shown are 
means ± SEM of the relative gene expression. n.d., not detectable; NCAM, neural cell adhesion molecule.
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expression was nearly 2-fold higher in cells differentiated with the new four-stage protocol
compared to the reference method (Table 2). The glucose transporter Glut2 and the transcription
factor Pdx1 were both weakly expressed. Higher expression levels were observed for Glut2
glucose transporter and β-cell transcription factor Pdx1 after the new optimized four-stage
protocol, with a 3-fold increase for Glut2 and 12-fold increase for Pdx1 (Table 2). Nestin and
NCAM levels were measured to analyse differentiation towards neuronal progeny. They were
both strongly expressed after the reference recipe, while cells from the new optimized four-stage
differentiation protocol showed a 2-fold decrease in nestin and a 6-fold decrease in NCAM
(Table 2). Gene expression analysis of amylase revealed only traces of mRNA expression in cells
from the reference protocol, while in cells from the new optimized four-stage one amylase
expression was undetectable (data not shown). Albumin expression, a marker for differentiation
towards hepatic progeny, was negligible in both protocols with levels typically at or below the
detection limit of real-time PCR (data not shown).
FACS sorting of CK19+ and CK19– cells differentiated from mouse ESCs, according to the 
optimized four-stage differentiation protocol
The pCK19-eYFP construct was successfully integrated into ESCs. Cell clones could be
selected and maintained in an undifferentiated state with identical morphology when compared
to wild-type ESCs. Moreover, growth rate of transfected and non-transfected cells was comparable,
indicating that their embryonic properties were not affected by transfection and subsequent
selection process. Interestingly, undifferentiated clones displayed eYFP positivity (91.0 ± 0.6%,
n = 4) that grossly decreased after formation of embryoid bodies to 13.4 ± 1.1% on day 5
(n = 7), 11.2 ± 1.2% on day 12 (n = 10), 6.8 ± 1.1% on day 19 (n = 8) and 1.6 ± 0.3% on day 26
(n = 16) of differentiation with the new optimized method (Fig. 2b). Analysis of gene expression
of endogenous CK19 significantly revealed 4–7-fold higher CK19 expression in CK19+ FACS-
sorted cells when compared to CK19– cells (Fig. 2c). Carbonic anhydrase 2 was analysed as a
Figure 1. Comparative schematic presentation of the two different protocols used for differentiation of mouse
embryonic stem cells (ESCs) into insulin-producing cells.
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second marker for duct cell progeny. Analysis of gene expression showed a 2-fold increase in
CK19+ cells at day 12 and a significant 9-fold increase in expression in CK19+ cells at day 26,
when compared to CK19– cells (Fig. 2d).
Gene expression profiles of pancreatic hormones and transcription factors in CK19+ and 
CK19– cells during differentiation from mouse ESCs
Quantitative analysis of gene expression revealed a low level of insulin in CK19+ and CK19–
cells up to day 19. A significant 80-fold increase in insulin gene expression was observed in
CK19+ cells on day 26 as compared to day 12 and day 19 (Fig. 3). Compared to CK19– cells,
insulin gene expression on day 26 was higher by a factor of 38 (Fig. 3), whereas the level of
insulin gene expression in CK19– cells did not change significantly. Glucagon gene expression
was not detectable at day 12 and day 19 (Fig. 3), while glucagon gene expression remained barely
detectable at day 26 in CK19+ cells, it increased to appreciable levels in CK19– cells 12 times
higher than in CK19+ cells (Fig. 3). Somatostatin gene expression was marginal throughout
the whole differentiation protocol at days 12, 19 and 26 in CK19+ cells (Fig. 3). In CK19– cells,
somatostatin gene expression was high at day 12 but had decreased by days 19 and 26 (Fig. 3).
Nevertheless, the expression level was seven times higher than in CK19+ cells (Fig. 3). Thus, CK19+
Figure 2. Selection of CK19+ and CK19– cells through FACS sorting of insulin-producing cells differentiated
from mouse embryonic stem cells (ESCs) according to the optimized four-stage differentiation protocol. (a) Schematic
presentation of the method used for separation of vital CK19+ and CK19– cells and non-vital cells by FACS sorting.
(b) Clonal ESCs differentiated according to the optimized four-stage differentiation protocol were analysed with respect
to size (FSC) and granularity (SSC) on day 26 of differentiation. Vital cells were gated (R1) and analysed for fluores-
cence intensity. CK19+ (R1+) and CK19– (R1–) cells were separated. (c) Cytokeratin-19 gene expression in FACS-sorted
CK19+ and CK19– cells. Values shown are means ± SEM of the relative gene expression of 5–13 experiments;
*P < 0.05, **P < 0.01. (d) Carbonic anhydrase 2 gene expression in FACS-sorted CK19+ and CK19– cells. Values shown are
means ± SEM of the relative gene expression of four to eight experiments; *P < 0.05. SSC, side scatter; FSC, forward scatter.
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cells can be classified as a population of monohormonal insulin-positive cells, while CK19– cells are
polyhormonal cells with similar levels of glucagon and somatostatin and low insulin gene expression.
The transcription factor Pdx1, a transactivator of the insulin gene, was expressed throughout the
differentiation from days 12–26 in CK19+ cells, whereas its expression in CK19– cells decreased
significantly from day 12–26 (Fig. 3). On day 26, Pdx1 expression in CK19+ cells was 3.5 times
higher than in CK19– cells. Nkx6.1, a transcription factor found in adult β-cells and during
vertebrate central nervous system development, was predominantly expressed in CK19– cells,
Figure 3. Comparison of the gene expression profile of pancreatic hormones insulin, glucagon and somatostatin, the
transcription factors Pdx1 and Nkx6.1 and embryonic marker Oct4, in CK19+ and CK19– cells, during differentiation
of mouse embryonic stem cells at days 12, 19 and 26 of the optimized four-stage differentiation protocol. Values
shown are means ± SEM of relative gene expression of 5–14 experiments. n.d., not detectable. *P < 0.05, **P < 0.01,
***P < 0.001, CK19+ compared to CK19– cells. †P < 0.05, ‡P < 0.01, compared to cells on day 12.
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in particular at day 12, while Nkx6.1 expression in CK19+ cells was significantly lower at each
time point, between four and five times, as compared to CK19– cells (Fig. 3). Oct4 was
expressed in CK19+ cells and CK19– cells throughout the differentiation protocol, but it
decreased towards the end of the differentiation protocol at day 26 (Fig. 3).
Gene expression profile of β-cell-specific structural markers in CK19+ and CK19– cells 
during differentiation of mouse ESCs
A significant increase in Glut2 glucose transporter and glucokinase gene expression was
observed in CK19+ and CK19– cells on day 26 as compared to day 12 and day 19 (Fig. 4). The
level of Glut2 expression was significantly higher in CK19+ than in CK19– cells at day 26
(Fig. 4). Both the Kir6.2 and Sur1 genes, which code for ATP-sensitive potassium channel
protein and the associated sulphonylurea receptor protein, were expressed throughout the whole
differentiation protocol at days 12, 19 and 26 in CK19+ and CK19– cells (Fig. 4).
Nestin and NCAM genes, which code for neuronal marker proteins, were also transcribed
throughout the whole differentiation protocol at days 12, 19 and 26 in CK19+ and CK19– cells
(Fig. 4). Both genes were preferentially expressed in CK19– cells (Fig. 4).
Thus, β-cell-specific expression of genes for glucose-sensing proteins as well as for proteins
making the β-cell depolarizing, predominated in CK19+ cells, while neuron-specific gene
expression prevailed in CK19– cells.
Immunocytochemical staining for C-peptide, of differentiated mouse ESCs
CK19+ cells had positive staining for C-peptide and insulin in the cytoplasm with a dot-like
appearance, providing evidence for ongoing active preproinsulin biosynthesis and for insulin
processing, while CK19– cells were negative for C-peptide. Nonetheless, staining for insulin
revealed that single CK19– cells exhibited a little immunoreactivity for insulin, albeit at very low
levels, which, however, did not co-stain with C-peptide (Fig. 5a). The MIN6 insulin-producing
β-cell line was used as positive control and showed distinct co-localization of C-peptide and
insulin in a manner similar to CK19+ cells (Fig. 6a).
Ultrastructure of differentiated mouse ESCs
CK19+ cells, in contrast to undifferentiated CK19– cells, exhibited clear signs of differentiation
with respect to subcellular organelles for synthesis, processing, storage and release of insulin.
CK19– cells possessed fewer mitochondria and few dilated cisternae of the endoplasmatic reticulum
with a minor number of ribosomes (Fig. 5b). The CK19+ cells showed both well-developed
rough endoplasmic reticulum and Golgi apparatus, well suited for insulin synthesis, and
insulin-secretory granules, together with a high number of mitochondria providing the basis for
sufficient energy supply for the cells’ protein synthesis. A distinct proportion of the secretory
granules were located in the vicinity of the plasma membrane with some single granules
undergoing exocytosis (Fig. 5b). This was comparable to the situation that can be observed in
MIN6 insulin-producing β-cells although the number of secretory granules in CK19+ cells was
lower than in MIN6 cells.
Insulin content in differentiated mouse ESCs
Embryonic stem cells differentiated according to the four-stage protocol contained detectable
amounts of insulin (0.37 ± 0.09 ng insulin/106 cells, n = 6) in the same range as found in cells
grown with the reference protocol (0.25 ± 0.07 ng insulin/106 cells, n = 3) (Fig. 7a). Analysis of
the CK19+ and CK19– cells revealed increased insulin content in CK19+ cells. Insulin content
was 50 times higher in CK19+ cells (113.3 ± 37.7 ng insulin/106 cells, n = 5) compared to
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CK19– cells (2.1 ± 0.5 ng insulin/106 cells, n = 5) (Fig. 7a). The removal of damaged and dead cells
through FACS-sorting also contributed to increased levels of insulin content in the sorted cells.
Insulin secretion in differentiated CK19+ and CK19– mouse ESCs
To evaluate whether CK19+ and CK19– cells release insulin in a glucose-dependent manner,
insulin secretion was determined. Both groups showed the same basal insulin release at 0 mm
Figure 4. Comparison of gene expression profile of the structural markers Glut2 glucose transporter, glucokinase,
Kir6.2, Sur1, nestin and NCAM in CK19+ and CK19– cells during differentiation of mouse embryonic stem cells
at days 12, 19 and 26 of the optimized four-stage differentiation protocol. Values shown are means ± SEM of the
relative gene expression of five to eight experiments. *P < 0.05, **P < 0.01, ***P < 0.001, CK19+ compared to CK19–
cells. †P < 0.05, ‡P < 0.01, compared to cells on day 12. NCAM, neural cell adhesion molecule.
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glucose. Incubation of CK19+ cells with 30 mm glucose resulted in release of 5.0 ± 1.8 ng insulin/
106 cells (n = 4) in 2 h, whereas CK19– cells showed no such increase (0.35 ± 0.09 ng insulin/106
cells, n = 5) on stimulation, when compared to basal insulin release rate (0.5 ± 0.17 ng insulin/106
cells, n = 5) (Fig. 7b).
DISCUSSION
Quantitative analysis of gene expression in mouse ESCs, which were differentiated according
to the reference protocol by Lumelsky et al. (2001), showed that all three major endocrine
Figure 5. Comparison of C-peptide and insulin staining of CK19+ and CK19– cells after differentiation of mouse
embryonic stem cells (ESCs) at day 26 of the optimized four-stage differentiation protocol. Ultrastructure of CK
19+ and CK19– ESCs at day 26 of the optimized four-stage differentiation protocol. (a) After FACS sorting CK19+ and
CK19– cells were seeded on glass slides and were stained for C-peptide (red) and insulin (green). Nuclei were counter-
stained with DAPI (blue). The merge is shown in yellow. Original magnification ×600. (b) Shown on the left side is an
electron micrograph of typical well-differentiated CK19+ cells with characteristics of endocrine insulin-producing cells
with well-developed rough endoplasmic reticulum (rER), Golgi apparatus (G) and secretory granules (arrowheads) and
a high number of mitochondria (arrows). Some of the secretory granules are situated near to the plasma membrane
(dashed line) ready for exocytosis (open arrowheads). On the right, shown for comparison, is an electron micrograph
of CK19– cells with a small number of mitochondria (arrows), dilated endoplasmic reticulum and a high number of
autophagic bodies (AB). Original magnification ×8000.
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hormones, insulin, glucagon and somatostatin, were readily expressed. Differentiation of ESCs
according to the newly developed optimized four-stage differentiation protocol, in contrast to
other published differentiation protocols (Lumelsky et al. 2001; Blyszczuk et al. 2003; Bai et al.
2005), yielded monohormonal insulin-producing cells, which virtually exclusively expressed
insulin, with no glucagon expression and minor somatostatin expression.
Through removal of nestin selection, we produced cells with a significantly reduced neuronal
character, as documented by reduction of expression levels of the neuronal markers nestin and
NCAM. At the same time, β-cell-like characteristics of these insulin-producing cells were reinforced
Figure 6. C-peptide and insulin staining and ultrastructure of MIN6 insulin-producing cells. (a) MIN6 cells were
seeded on glass slides and were stained for C-peptide (red) and insulin (green); nuclei were counterstained with DAPI
(blue). The merge is shown in yellow. Original magnification ×600. (b) The electron micrograph of MIN6 insulin-
producing cells shows the typical endocrine morphology with high numbers of mitochondria (arrows), well devel-
oped rough endoplasmic reticulum (rER), Golgi apparatus (G) and secretory granules (arrowheads) some of them ready
for exocytosis (open arrowheads). Original magnification ×8000.
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by high the gene expression level of the Glut2 glucose transporter and the transcription factor
Pdx1. High levels of expression were also present for other β-cell characteristic genes, namely
of the glucose sensor enzyme glucokinase as well as the potassium channel Kir6.2 and the sulpho-
nylurea receptor Sur1. In parallel, markers for differentiation towards ductal cells, namely CK19
and CA2, were significantly increased. On the other hand, lack of expression of amylase and
albumin excluded significant differentiation towards exocrine pancreas and hepatic progeny.
These results support the contention that the removal of the nestin selection step from
the differentiation protocol drives ESCs to the direction of insulin-producing cells and
reduces neuronal characteristics of the differentiated cells. Thus, selection strategies focused on
nestin expression (Lumelsky et al. 2001; Hori et al. 2002; Blyszczuk et al. 2003; Moritoh et al.
2003; Miyazaki et al. 2004; Bai et al. 2005) are not particularly suited to differentiation of
ESCs into insulin-producing cells (Rajagopal et al. 2003; Hansson et al. 2004; Sipione et al.
2004). Not surprisingly, therefore, differentiation protocols that yielded cells with increased
nestin positivity (Blyszczuk et al. 2003) were not significantly superior to the protocol devised
by Lumelsky et al. (2001).
Therefore, rather than on nestin-positive cells, we focused our attention on CK19+ as a
selection marker for insulin-producing cells. CK19+ ductal cells are generally considered to be
progenitors for endocrine cells during pancreatic organogenesis (Rutter 1980; Slack 1995;
Bouwens & De Blay 1996; Bouwens et al. 1997, 1998). In vitro analysis of purified CK19+ cells
demonstrated the capacity to proliferate and differentiate into islet cells (Bouwens et al. 1997,
1998, 2005; Bonner-Weir et al. 2000; Gao et al. 2003, 2005). In addition, recent work has shown
that human embryonic stem cells follow, during their differentiation towards endocrine cells, the
same developmental pathway known from in vivo development of the pancreas (D’Amour et al.
2005, 2006). Thus, it is clear that during in vitro differentiation of stem cells the last differentiation
step towards β-cell type must occur via a CK19+ cell population that expresses insulin. Moreover,
the expression of CK19 as a marker of pancreatic ducts is in line with endodermal origin, and
Figure 7. Comparison of insulin content of mouse embryonic stem cells after differentiation into insulin-producing
cells, according to the reference differentiation protocol by Lumelsky et al. (2001) to the optimized four-stage
differentiation protocol, as well as of the latter cells after separation into CK19+ and CK19– cells. Comparison of
insulin release in CK19+ and CK19– cells after 2 h static incubation with 0 mm and 30 mm glucose. (a) Values shown
are means ± SEM of the insulin content (ng/106 cells) of three to six experiments. ***P < 0.001, CK19+ compared to
CK19– cells. ‡P < 0.01, CK19+ compared to cells from the reference protocol. (b) Values shown are means ± SEM of
the insulin released (ng/106 cells) in 2 h of three to five experiments. *P < 0.05, CK19+ compared to CK19– cells.
†P < 0.05, compared to CK19+ cells treated with 0 mm glucose. For comparison, insulin content of the MIN6 insulin-
producing cells was 817.6 ± 123.5 ng insulin/106 cells, n = 64.
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clearly distinguishes such cells from cells of neuroectodermal progeny (Bouwens 2004;
Hisatomi et al. 2004; Bouwens et al. 2005).
Following this assumption, we have on the basis of the new optimized differentiation
protocol, set up a separation strategy using FACS sorting of fluorescent CK19+ and non-fluorescent
CK19– cells. We have used the CK19 promoter to control expression of eYFP in mouse ESCs
during their differentiation towards insulin-producing cells. Previous studies have shown that the
CK19 promoter is particularly potent to target duct cells (Brembeck et al. 2001). Two distinct
cell populations, CK19+ and CK19– cells, could be successfully separated and analysed using
this FACS sorting procedure. Gene expression analysis of endogenous CK19 revealed that this
gene is predominantly expressed in the FACS-sorted CK19+ population. Thus, our selection
procedure purifies ductal progenitor cells and separates them successfully from the CK19–, non-
ductal cell population. A detailed molecular, biochemical and morphological analysis revealed
that CK19+ cells represent a population of differentiated ESCs, which express the insulin prohor-
mone gene, and process, store and release insulin.
We obtained 1.6% CK19+ cells, which, in comparison with the CK19– cell fraction, had a
nearly 40-fold higher level of insulin gene expression and a 50-fold higher content of insulin.
This insulin content is around 450 times higher than that obtained using the reference protocol
of Lumelsky et al. (2001) and still around 300 times higher than the optimized four-stage
differentiation protocol, from which we started the CK19 separation procedure. Thus, this separation
strategy of FACS sorting is far more efficient then previously published differentiation protocols
(Lumelsky et al. 2001; Hori et al. 2002; Blyszczuk et al. 2003, 2004; Miyazaki et al. 2004; Bai
et al. 2005; Shiroi et al. 2005).
When compared to the clonal insulin-producing cell lines RINm5F and MIN6, which like
differentiated embryonic stem cells also reside in a tissue culture milieu, the level of insulin
content in MIN6 insulin-producing cells is about seven times higher, and in RINm5F cells it is
about 13 times lower than found in CK19+ cells. Isolated islets of Langerhans, containing β-cells
and other endocrine and non-endocrine cells types, lose insulin content and expression within
less than 1–2 weeks (Weinberg et al. 2007). Thus, it is not surprising that embryonic stem cells
differentiated in vitro towards insulin-producing cells do not reach insulin content and expression
levels comparable to those of mature freshly isolated β-cells.
The CK19+ cells expressed nearly 40 times more insulin but 12 times less glucagon and 7
times less somatostatin than CK19– cells. Thus, CK19+ cells can be classified as monohormonal
insulin-positive cells, while CK19– cells are polyhormonal cells with similar levels of glucagon
and somatostatin but low insulin gene expression. In contrast to the CK19– ones, CK19+ cells
also exhibited a glucose-responsive insulin secretion.
Gene expression of Glut2 glucose transporter and transcription factor Pdx1 were also higher
in CK19+ cells. Expression levels of genes, which are known to be present both in β-cells and
neuronal cells, namely of the potassium channel Kir6.2 and of the sulphonylurea receptor Sur1,
were similar in both fractions, while gene expression levels of the typical neuronal markers such
as nestin and NCAM were higher in CK19– cells. This is in accordance with the observation that
NCAM is significantly expressed only in pancreatic α-cells while it is low in β-cells and absent in
acinar and duct cells (Cirulli et al. 1994). The significantly higher expression of the transcription
factor Nkx6.1 in CK19– cells supports the contention that this is also a gene with primary importance
for neuronal development (Liu et al. 2003; Przyborski et al. 2003). This provides further support
for the hypothesis that differentiation via neuronal precursors does not generate insulin-producing
cells. CK19+ cells exhibit the typical characteristics of pancreatic β-cells. In contrast to the CK19–
cell population, CK19+ cells are also C-peptide and insulin-positive and show, on ultrastructural
analysis, typical characteristics of insulin-secretory cells, namely well-developed rough
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endoplasmic reticulum, Golgi apparatus and secretory granules. Thus, the small proportion of
C-peptide-positive cells that have been reported after ESCs had passed through differentiation
protocols towards insulin-producing cells (Blyszczuk et al. 2004; Paek et al. 2005) can be con-
sidered to be the source of the C-peptide-positive cells with typical ultrastructural characteristics
of secretory cells, which we have found in the present study in the fraction of the CK19+ cells.
During the course of differentiation from ESCs towards insulin-producing cells, a fraction
of the cells undergoes cell death through apoptosis. Thus, at the end of the differentiation
procedure, the cell population contains a proportion of dead cells (Rajagopal et al. 2003; Hansson
et al. 2004; Sipione et al. 2004; Duval et al. 2006). These apoptotic cells are particularly prone
to uptake of insulin from the extracellular space (Rajagopal et al. 2003). This can lead to over-
estimation of the efficiency of a differentiation protocol (Hansson et al. 2004). However,
because differentiation culture media require insulin supplementation for proper proliferation of
the cells, it is necessary to separate the dead cells from the total cell population. Therefore, this
separation-out of dead cells is part of our FACS sorting procedure (Fig. 2). Thus, the obtained
populations of CK19+ and CK19– cells were not contaminated with apoptotic cells, excluding
an overestimation of cellular insulin content due to uptake from the differentiation medium.
In conclusion, our results show that this combined procedure is suitable for obtaining
C-peptide-positive, glucose-responsive insulin-secreting CK19+ cells. That the population of
insulin-positive cells are, in addition, positive for CK19, provides strong support for the concept
of ductal origin of insulin-producing cells (Bonner-Weir et al. 2000, 2004; Gao et al. 2003,
2005; Bouwens et al. 2005). Thus, these cells represent an endocrine precursor cell type with
typical ultrastructural characteristics of insulin-secretory cells, potentially suitable for insulin
replacement therapy in diabetes.
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